Chung-Yu Huang

3PUBLICATIONS
25CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 18, 2022
Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study.

Nai-Jung Chiang, Kien Thiam Tan, Li-Yuan Bai

|Sep 20, 2021
Pdia4 regulates β-cell pathogenesis in diabetes: molecular mechanism and targeted therapy.

Tien-Fen Kuo, Shuo-Wen Hsu, Shou-Hsien Huang

|Dec 16, 2020
The Inflammatory Cytokine Profile of Patients with Malignant Pleural Effusion Treated with Pleurodesis.

Li-Han Hsu, Thomas C Soong, Nei-Min Chu

Pageof 1